SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Tuesday reported a loss of $1.3 million in its fourth quarter.

The San Diego-based company said it had a loss of 3 cents per share.

The biopharmaceutical company posted revenue of $5 million in the period.

For the year, the company reported that its loss narrowed to $15.7 million, or 45 cents per share. Revenue was reported as $10 million.

In the final minutes of trading on Tuesday, the company's shares hit $1.37. A year ago, they were trading at 71 cents.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News